Cargando…
Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations
Because guidelines and recommendations in response to multiple randomized clinical trials (RCTs) of new therapies undergo rapid changes, antithrombotic therapies for patients after acute coronary syndrome, or percutaneous coronary intervention, are becoming more complex in daily clinical practice. T...
Autores principales: | Kwon, Osung, Park, Duk-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627845/ https://www.ncbi.nlm.nih.gov/pubmed/36340250 http://dx.doi.org/10.1016/j.jacasi.2021.12.005 |
Ejemplares similares
-
Patient-tailored antithrombotic therapy following percutaneous coronary intervention
por: van der Sangen, Niels M R, et al.
Publicado: (2021) -
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary Artery Disease
por: Park, Sangwoo, et al.
Publicado: (2023) -
Percutaneous Coronary Intervention for Left Main Coronary Artery Disease: Present Status and Future Perspectives
por: Park, Sangwoo, et al.
Publicado: (2022) -
Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
por: Kozieł, Monika, et al.
Publicado: (2020) -
Physiology-Based Revascularization: A New Approach to Plan and Optimize Percutaneous Coronary Intervention
por: Lee, Joo Myung, et al.
Publicado: (2021)